Butler M

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

14 papers · 6 preprints · ORCID

ArticlePsilocybin

Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.

Bhagavan C, Carter O, Nielsen G +12

Europe PMC2026
ArticlePsilocybin

Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.

Rucker JJ, Mantingh T, Kerr-Gaffney J +26

Europe PMC2026
ArticleKetamine

(Es)ketamine in functional neurological disorder: a systematic review.

Tamilson B, Chitolie M, Coebergh J +5

Europe PMC2026
ArticlePsychedelics

Ten practical suggestions for setting up a psychedelic study.

Caulfield A, Butler M, Mehta MA

Europe PMC2026
PreprintPsychedelics

Tripping on context: Characteristics and predictors of placebo and nocebo psychedelic effects

Stein MV, Butler M, Chapman S +2

Europe PMC2026
ArticlePsychedelics

Characterising the clinical associations of hallucinogen persisting perception disorder: a retrospective cohort study.

Butler M, Moore E, Rucker JJ +6

Europe PMC2026
ArticlePsychedelics

How to set up a psychedelic study: Unique considerations for research involving human participants.

Glennon MJ, Bird CIV, Yadav P +18

Europe PMC2026
PreprintPsychedelics

Ten simple rules for setting up a psychedelic study

Caulfield A, Butler M, Mehta M

Europe PMC2026
PreprintPsilocybin

A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants

Bhagavan C, Carter O, Nielsen G +12

Europe PMC2025
ArticlePsilocybin

Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study.

Bhagavan C, Bryson A, Carter O +13

Europe PMC2025
PreprintPsychedelics

Characterising the clinical associations of hallucinogen persisting perceptual disorder: a retrospective cohort study

Butler M, Moore E, Rucker J +6

Europe PMC2025
PreprintPsilocybin

Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol

Butler M, Bird C, Maggio C +14

Europe PMC2025
ArticlePsilocybin

Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.

Rucker J, Butler M, Hambleton S +8

Europe PMC2024
PreprintPsilocybin

Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol

Butler M, Bird C, Maggio C +14

Europe PMC2024
ArticlePsilocybin

Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy Participants.

Bhagavan C, Kanaan R, Carter O +13

Europe PMC2024
ArticlePsilocybin

Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol.

Butler M, Bird C, Maggio C +14

Europe PMC2024
ArticleAyahuasca

Corrigendum: Ceremonial ayahuasca in amazonian retreats-mental health and epigenetic outcomes from a six-month naturalistic study.

Ruffell SGD, Netzband N, Tsang W +8

Europe PMC2023
ArticlePsilocybin

Expectancy in placebo-controlled trials of psychedelics: if so, so what?

Butler M, Jelen L, Rucker J

Europe PMC2022
ArticleAyahuasca

Ceremonial Ayahuasca in Amazonian Retreats-Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study.

Ruffell SGD, Netzband N, Tsang W +7

Europe PMC2021
ArticlePsilocybin

Psychedelic treatment of functional neurological disorder: a systematic review.

Butler M, Seynaeve M, Nicholson TR +5

Europe PMC2020